We are live on
!
Find out more
Immunic
IMUX
IMUX
60 hedge funds and large institutions have $116M invested in Immunic in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 29 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
222% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 9
23% more call options, than puts
Call options by funds: $1.24M | Put options by funds: $1.01M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.06% less ownership
Funds ownership: 4.39% → 4.34% (-0.06%)
5% less funds holding
Funds holding: 63 → 60 (-3)
22% less capital invested
Capital invested by funds: $148M → $116M (-$32.6M)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Holders
60
Holders Change
-3
Holders Change %
-4.76%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
29
Reduced
9
Closed
8
Calls
$1.24M
Puts
$1.01M
Net Calls
+$229K
Net Calls Change
-$358K
Top Buyers
| 1 |
BlackRock
New York
|
+$5.42M |
| 2 |
State Street
Boston,
Massachusetts
|
+$1.41M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.3M |
| 4 |
Millennium Management
New York
|
+$1.11M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$900K |
